Adam Patterson


Dr. Adam Patterson is associate professor at the University of Auckland where he has led the translational therapeutics team at the Auckland Cancer Society Research Centre since 2010. Dr. Patterson also leads the Tumour Microenvironment Flagship of the Maurice Wilkins Centre for Molecular Biodiscovery. He has a broad interest in the metabolism of bioreductive prodrugs and their application as antitumour agents, with particular emphasis on selective targeting of the tumor microenvironment.

Dr. Patterson obtained his BA in Biochemistry at the University of Oxford, UK, and his PhD in the field of Bioreductive prodrugs based at the Institute of Molecular Medicine, Oxford and the Medical Research Council Radiobiology Unit, Harwell, UK.